Latest news
Sionna’s experimental cystic fibrosis pill falls flat in mid-stage trial - STATSTAT · Mon, 10 Aug 2026 15:34:15 GMTBiotech veteran with 25 years’ experience joins Ernexa board - Stock TitanStock Titan · Mon, 10 Aug 2026 13:01:00 GMTWhat therapeutic validation milestones are positioning UK biotech companies for? - Kalkine MediaKalkine Media · Mon, 10 Aug 2026 09:48:00 GMTBraveheart Bio’s $382M IPO for Heart Drug Leads a Big Week for Biotech IPOs - MedCity NewsMedCity News · Mon, 10 Aug 2026 03:12:34 GMTGlobal pharma giants turn to Chinese biotech to tap innovation, valuation growth - South China Morning PostSouth China Morning Post · Sat, 08 Aug 2026 10:34:51 GMTBioMarin axes $270M rare disease asset after missing phase 3 endpoint - Fierce BiotechFierce Biotech · Fri, 07 Aug 2026 13:10:41 GMTTarsus pays $450M for Alkeus and its ph. 3 retinal disease drug - Fierce BiotechFierce Biotech · Thu, 06 Aug 2026 14:30:00 GMTBioVie’s stock sinks 50% as company uses composite endpoint to make case for Parkinson’s program - Fierce BiotechFierce Biotech · Thu, 06 Aug 2026 13:40:09 GMT